UREMIC PRURITUS
Clinical trials for UREMIC PRURITUS explained in plain language.
Never miss a new study
Get alerted when new UREMIC PRURITUS trials appear
Sign up with your email to follow new studies for UREMIC PRURITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug MR13A9 shows promise for Dialysis-Related itching
Symptom relief CompletedThis Phase 2 study tested a drug called MR13A9 in 247 Japanese adults on hemodialysis who had severe itching (uremic pruritus). Participants received either MR13A9 or a placebo intravenously. The goal was to see if the drug reduces itch intensity over 8 weeks. Results could lead …
Matched conditions: UREMIC PRURITUS
Phase: PHASE2 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
New drug aims to stop the agonizing itch of dialysis
Symptom relief CompletedThis completed Phase 3 trial tested a drug called MR13A9 in 178 adults on hemodialysis who suffer from severe itching (uremic pruritus). The study compared MR13A9 to a placebo to see if it reduces itch intensity, measured by a daily 0-10 rating scale. If successful, MR13A9 could …
Matched conditions: UREMIC PRURITUS
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 26, 2026 15:55 UTC
-
New drug may scratch the itch for dialysis patients
Symptom relief CompletedThis study tested a drug called difelikefalin to see if it can reduce moderate-to-severe itching in Chinese adults on hemodialysis. 260 participants received either the drug or a placebo three times a week for 12 weeks. The main goal was to measure changes in itching intensity us…
Matched conditions: UREMIC PRURITUS
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Symptom relief
Last updated Jun 26, 2026 15:36 UTC